Status:
COMPLETED
SKAMo-1: Characterization of the Upper Layers of Skin
Lead Sponsor:
Eclypia
Conditions:
Diabetes
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Diabetes is a frequent disease characterized by chronic hyperglycemia, and its prevalence is increasing worldwide. Historically, patients with diabetes were required to monitor capillary blood glucose...
Eligibility Criteria
Inclusion
- Male or female aged ≥ 18 years and ≤ 60 years
- Signed informed consent
- Person who is affiliated to a social security scheme or who is beneficiary of such a scheme
Exclusion
- Body mass index (BMI) \> 30 kg/m2
- Any acute or chronic disease with vascular impact
- Any cutaneous disease on sites implicated in the study (dorsum of the forearm)
- Allergy to one of the material used in the sham device and during the procedure of the study
- The persons mentioned in articles L1121-5 to L1121-8 of the public health code may not be included in this research
- Subject who would receive more than 4500 euros in compensation due to his or her participation in other research involving the human person in the 12 months preceding this study
Key Trial Info
Start Date :
March 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 27 2023
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT06044532
Start Date
March 1 2023
End Date
April 27 2023
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Grenoble Alpes
Grenoble, France, 38043